ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Accumulated OCI

Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.

No reported Accumulated OCI figures are available to summarize.

Accumulated OCI history

Currency unavailable · from the balance sheet

No Accumulated OCI data reported for this period type.

Accumulated OCI vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Accumulated OCI for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PRQRProQR Therapeutics N.V.Mar 2026€28.33M EUR-2.8%-1.8%28.6%
MGTXMeiraGTx Holdings plcMar 2026$2.58M USD+150.9%-26.4%1.1%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$0 USD——0.0%
RNAAtrium Therapeutics, Inc.Mar 2026$0 USD——0.0%
PRMEPrime Medicine, Inc.Mar 2026-$1K USD+93.3%—0.0%
STOKStoke Therapeutics, Inc.Mar 2026-$115K USD-10.6%—0.0%
WVEWave Life Sciences Ltd.Mar 2026-$254K USD-24.5%—0.0%
BNTCBenitec Biopharma Inc.Mar 2026-$952K USD-33.0%—0.5%
SLNSilence Therapeutics plcMar 2026-$3.37M USD-141.7%—2.9%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-10.6%-14.1%0.0%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.